ArticleFrontiers in oncology2022

Case Report: Dacomitinib is effective in lung adenocarcinoma with rare EGFR mutation L747P and brain metastases.

Yibin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.